T Cells Archives

MaxCyte® Enabled Innovative SARS-CoV-2 Vaccine Development
Gallery
MaxCyte® Enabled Innovative SARS-CoV-2 Vaccine Development

MaxCyte® Enabled Innovative SARS-CoV-2 Vaccine Development

St Jones2022-08-10T16:13:05+00:00August 10th, 2022|Comments Off

Hematopoietic Stem Cell Electroporation for HDR-Mediated Correction of an X-Linked Blood Disorder
Gallery
Hematopoietic Stem Cell Electroporation for HDR-Mediated Correction of an X-Linked Blood Disorder

Hematopoietic Stem Cell Electroporation for HDR-Mediated Correction of an X-Linked Blood Disorder

St Jones2022-08-10T15:54:57+00:00August 10th, 2022|Comments Off

Efficient and Scalable T Cell Engineering for Advancing Cancer Immunotherapy of Hepatocellular Carcinoma by a cGmp-Compliant Non-Viral Cell Engineering Platform
Gallery
Efficient and Scalable T Cell Engineering for Advancing Cancer Immunotherapy of Hepatocellular Carcinoma by a cGmp-Compliant Non-Viral Cell Engineering Platform

Efficient and Scalable T Cell Engineering for Advancing Cancer Immunotherapy of Hepatocellular Carcinoma by a cGmp-Compliant Non-Viral Cell Engineering Platform

St Jones2022-06-24T22:14:33+00:00June 24th, 2022|Comments Off

Multi-gene Knockdown for Improved Therapeutic Efficacy
Gallery
Multi-gene Knockdown for Improved Therapeutic Efficacy

Multi-gene Knockdown for Improved Therapeutic Efficacy

St Jones2022-06-24T21:42:38+00:00June 8th, 2022|Comments Off

Multiplex CRISPR-mediated Gene Editing Towards the Creation of a Universal CAR T Cell
Gallery
Multiplex CRISPR-mediated Gene Editing Towards the Creation of a Universal CAR T Cell

Multiplex CRISPR-mediated Gene Editing Towards the Creation of a Universal CAR T Cell

St Jones2022-06-24T21:43:29+00:00June 8th, 2022|Comments Off

Preclinical Optimization of Gene Editing for Adoptive T Cell Therapy with High Fidelity CRISPR/Cas9 Ribonucleoproteins
Gallery
Preclinical Optimization of Gene Editing for Adoptive T Cell Therapy with High Fidelity CRISPR/Cas9 Ribonucleoproteins

Preclinical Optimization of Gene Editing for Adoptive T Cell Therapy with High Fidelity CRISPR/Cas9 Ribonucleoproteins

St Jones2022-06-08T17:48:32+00:00June 6th, 2022|Comments Off

Scalable Electroporation of Adult Keratinocytes with Multiplexed CRISPR Ribonucleoproteins for the Development of Novel Cell Therapeutics
Gallery
Scalable Electroporation of Adult Keratinocytes with Multiplexed CRISPR Ribonucleoproteins for the Development of Novel Cell Therapeutics

Scalable Electroporation of Adult Keratinocytes with Multiplexed CRISPR Ribonucleoproteins for the Development of Novel Cell Therapeutics

St Jones2022-05-11T17:40:23+00:00May 10th, 2022|Comments Off

In Vitro Characterization of CD19 CAR T Cells Derived by Electroporation of mRNA
Gallery
In Vitro Characterization of CD19 CAR T Cells Derived by Electroporation of mRNA

In Vitro Characterization of CD19 CAR T Cells Derived by Electroporation of mRNA

St Jones2022-05-07T03:02:50+00:00May 6th, 2022|Comments Off

MaxCyte®: A Versatile Tool for SARS-CoV-2 Response
Gallery
MaxCyte®: A Versatile Tool for SARS-CoV-2 Response

MaxCyte®: A Versatile Tool for SARS-CoV-2 Response

St Jones2022-04-27T18:34:44+00:00April 25th, 2022|Comments Off

MaxCyte® Enables a cGMP-Compatible Manufacturing Process for Highly Efficient T Cell Engineering
Gallery
MaxCyte® Enables a cGMP-Compatible Manufacturing Process for Highly Efficient T Cell Engineering

MaxCyte® Enables a cGMP-Compatible Manufacturing Process for Highly Efficient T Cell Engineering

St Jones2022-04-27T16:36:43+00:00April 22nd, 2022|Comments Off

MaxCyte® Enabled Innovative SARS-CoV-2 Vaccine Development

Hematopoietic Stem Cell Electroporation for HDR-Mediated Correction of an X-Linked Blood Disorder

Efficient and Scalable T Cell Engineering for Advancing Cancer Immunotherapy of Hepatocellular Carcinoma by a cGmp-Compliant Non-Viral Cell Engineering Platform

Multi-gene Knockdown for Improved Therapeutic Efficacy

Multiplex CRISPR-mediated Gene Editing Towards the Creation of a Universal CAR T Cell

Preclinical Optimization of Gene Editing for Adoptive T Cell Therapy with High Fidelity CRISPR/Cas9 Ribonucleoproteins

Scalable Electroporation of Adult Keratinocytes with Multiplexed CRISPR Ribonucleoproteins for the Development of Novel Cell Therapeutics

In Vitro Characterization of CD19 CAR T Cells Derived by Electroporation of mRNA

MaxCyte®: A Versatile Tool for SARS-CoV-2 Response

MaxCyte® Enables a cGMP-Compatible Manufacturing Process for Highly Efficient T Cell Engineering

MaxCyte, Inc.

Life Sciences

Consumables

Careers

Legal

Applications

Investors

ExPERT Platform

MaxCyte Minutes

Instruments

About Us

Resources

Distributors